Innovative approaches for pediatric cancer immunotherapy

This course aims to synthesize the state-of-the-art and the therapeutic perspectives related to harnessing children's immune system to target pediatric tumors. Encompassing topics from biological characteristics of pediatric cancers and childhood immunity to cutting-edge cellular engineering developments, it will focus on pediatric solid tumors while drawing lessons from recent successes and remaining challenges in childhood hematologic malignancies. The course will bring together leading international stakeholders whose recent preclinical and clinical breakthroughs suggest promising therapeutic improvements ahead.